Patients' preferences in non-curable cancer disease

16Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Eliciting and integrating patients' preferences in decision-making in palliative oncology is an important criterion for the quality of end-of-life care. It is an essential prerequisite in supporting the integrity of patients' decision-making process, enhancing patients' right to self-determination and facilitating patients' autonomy. In this review we summarize the data on: (1) patients' preference for a decisional model in advanced cancer, (2) patients' preferences for quality versus length of life and the enrollment of patients in early-phase clinical studies, and (3) preferences for caregiver involvement in decision-making. Timely assessment of patients' preferences enables advance care planning with respect to considering patients' values, discussing therapy goals and planning for patients' end-of-life care. It helps avoiding overtreatment near the end of life and giving care that is aligned to patients' wishes and family capacities.

Cite

CITATION STYLE

APA

Laryionava, K., & Winkler, E. C. (2019, February 1). Patients’ preferences in non-curable cancer disease. Oncology Research and Treatment. S. Karger AG. https://doi.org/10.1159/000496120

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free